Preserving Patient Access to Home Infusion Act
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
The Preserving Patient Access to Home Infusion Act aims to ensure Medicare patients have continued access to home infusion therapy. It expands the definition of covered home infusion services to include pharmacy services and certain medications administered without a pump. The bill also allows nurse practitioners and physician assistants to be involved in creating and reviewing care plans, and clarifies payment rules for home infusion drugs administered outside of a patient’s home.
Key provisions
- Includes pharmacy services and drug preparation/compounding as covered home infusion therapy.
- Allows nurse practitioners and physician assistants to establish and review home infusion care plans.
- Clarifies payment rules for home infusion drugs administered outside of a patient’s home.
- Defines ‘specified non-pump drug or biological’ to include intravenous medications not administered through a pump.
- Establishes a transitional rule for single payment amounts related to home infusion therapy starting in 2026.
- Specifies a 50% payment rate when a home infusion supplier is not physically present during drug administration.
- Addresses payment for home infusion supplies furnished on the same day as the infusion drug.
- Defines ‘applicable items and services’ for payment purposes related to home infusion therapy.
Who is affected
- Medicare beneficiaries
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
30 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours